- Report
- April 2023
- 120 Pages
Global
From €4315EUR$4,750USD£3,724GBP
- Report
- April 2023
- 120 Pages
Global
From €4315EUR$4,750USD£3,724GBP
- Report
- November 2023
- 117 Pages
Global
From €4088EUR$4,500USD£3,528GBP
- Report
- June 2025
- 400 Pages
Global
From €4496EUR$4,949USD£3,880GBP
- Report
- June 2025
- 400 Pages
Global
From €4496EUR$4,949USD£3,880GBP
- Report
- June 2025
- 400 Pages
Global
From €4496EUR$4,949USD£3,880GBP
- Report
- January 2025
- 250 Pages
Global
From €4541EUR$4,999USD£3,919GBP
- Report
- August 2024
- 200 Pages
Global
From €4496EUR$4,949USD£3,880GBP
- Report
- May 2024
- 160 Pages
Global
From €4514EUR$4,969USD£3,896GBP
- Report
- November 2024
- 87 Pages
Europe
From €3134EUR$3,450USD£2,705GBP
- Report
- July 2023
- 188 Pages
Global
From €4042EUR$4,450USD£3,489GBP
- Report
- July 2023
- 127 Pages
Australia
From €3134EUR$3,450USD£2,705GBP
- Report
- December 2024
- 438 Pages
Global
From €3634EUR$4,000USD£3,136GBP
- Report
- August 2022
- 109 Pages
Global
From €3588EUR$3,950USD£3,097GBP
- Report
- February 2024
- 250 Pages
Global
€4538EUR$4,995USD£3,916GBP
- Report
- December 2023
- 212 Pages
Global
€4538EUR$4,995USD£3,916GBP
- Report
- June 2026
- 357 Pages
United Kingdom
From €598EUR$682USD£499GBP
- Report
- May 2026
- 191 Pages
Australia
From €4406EUR$4,850USD£3,803GBP
- Report
- May 2026
- 194 Pages
Germany
From €4406EUR$4,850USD£3,803GBP
- Report
- May 2026
- 195 Pages
India
From €4406EUR$4,850USD£3,803GBP

The Cancer Research market is a subset of the Drug Discovery market, focused on the development of treatments for cancer. This market is composed of a variety of stakeholders, including pharmaceutical companies, research institutions, and government agencies. These stakeholders collaborate to develop new treatments and therapies for cancer, as well as to improve existing treatments. The market is driven by the need to find new and effective treatments for cancer, as well as to improve the quality of life for those affected by the disease.
The Cancer Research market is highly competitive, with many companies vying for a share of the market. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. These companies are engaged in research and development of new treatments and therapies for cancer, as well as the marketing and distribution of existing treatments. Show Less Read more